# Actinium Pharmaceuticals Grants Inducement Equity Awards to New CFO and SVP

- URL: https://stocks.freetheai.org/news/actinium-pharmaceuticals-grants-inducement-equity-awards-to-new-cfo-and-svp-33285d
- Published: 2026-10-16T21:00:00Z
- Category: company_news; sentiment: neutral; impact: low
- Symbols: [AMEX:ATNM](https://stocks.freetheai.org/symbols/AMEX-ATNM)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Actinium Pharmaceuticals, Inc. (ATNM) has awarded stock options and restricted stock units (RSUs) to its newly appointed Chief Financial Officer, Matt David, and Senior Vice President, Sean Maenpaa. The inducement grants feature multi-year vesting schedules, with a portion of the RSUs linked to specific corporate operational milestones. Shares of the company rose 6.60% to $1.13 following the announcement.

The compensation structure combines time-based equity with performance-contingent awards to align executive compensation with business execution. Under the awards, Matt David received 250,000 options at a $0.97 strike price, 250,000 time-based RSUs, and up to 75,000 performance-based RSUs. Sean Maenpaa was granted 40,000 options at a $1.06 strike price, 20,000 time-based RSUs, and 50,000 milestone-linked RSUs. Both option grants carry ten-year terms.

Investors will be watching for progress on corporate milestones, potential business development deals, financing activities, and clinical trial updates that could trigger the performance-based RSUs.

## Key points

- Actinium Pharmaceuticals granted inducement options and RSUs to new CFO Matt David and SVP Sean Maenpaa.
- CFO Matt David received 250,000 stock options at $0.97, 250,000 time-based RSUs, and up to 75,000 performance RSUs.
- SVP Sean Maenpaa received 40,000 stock options at $1.06, 20,000 time-based RSUs, and 50,000 performance RSUs.
- Both option grants feature a ten-year expiration term.
- Actinium Pharmaceuticals stock gained 6.60% to close at $1.13.

## Questions and answers

### What equity awards did Actinium Pharmaceuticals grant to its new CFO?

CFO Matt David received 250,000 stock options with a $0.97 strike price and a ten-year term, 250,000 time-vested RSUs, and up to 75,000 milestone-based RSUs.

### What equity compensation was granted to Actinium's new SVP?

SVP Sean Maenpaa received 40,000 stock options with a $1.06 strike price and a ten-year term, 20,000 time-vested RSUs, and 50,000 milestone-based RSUs.

### How did ATNM stock react to the leadership compensation announcement?

Shares of Actinium Pharmaceuticals (ATNM) increased by 6.60% to reach $1.13.